Disposition of 10000 shares by Steven Baileys of SunLink Health at 1.67 subject to Rule 16b-3

Read at macroaxis.com

Published over a month ago View all stories for Cyren | Cyren Hype Analysis

Disposition of 10000 director stock option at 1.67 of SunLink Health by Steven Baileys on 4th of November 2024. This event was filed by SunLink Health Systems with SEC on 2021-10-19. Statement of changes in beneficial ownership - SEC Form 4

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cyren pink sheet to make a market-neutral strategy. Peer analysis of Cyren could also be used in its relative valuation, which is a method of valuing Cyren by comparing valuation metrics with similar companies.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

If you are still planning to invest in Cyren check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyren's history and understand the potential risks before investing.